S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
EPA:NRX

Naturex (NRX) Stock Price, News & Analysis

€134.40
0.00 (0.00%)
(As of 09/12/2018)
Today's Range
€134.40
€134.80
50-Day Range
€134.40
€134.40
52-Week Range
N/A
Volume
516 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Naturex

Naturex S.A. sources, produces, and sells natural ingredients for the food, health, and beauty sectors. The company offers various products for use in the food and beverage industries, including NAT color, a color solution; NAT stabil, an ingredient for food preservation; NAT healthy botanicals; IALIN thaumatin; NAT texture, a pectin for thickening, gelling, and stabilizing; NAT arom, natural flavoring ingredients; and NAT taste to enhance taste, as well as quillaia extracts under the UPTAIA and SAPNOV names. It also provides NAT fruits&greens, which are a range of vegetable and superfood powders that preserve raw material integrity for organoleptic and/or nutrition properties; NAT activ, a range of botanicals; NAT pharma, an active pharmaceutical ingredient for use in herbal medicines; and NAT life, a natural ingredient for use in the dietary supplement market. In addition, the company offers NAT select, a botanical extract; NAT oleis, a botanical oil; and NAT beauty, an active ingredient for use in personal care products. Further, it provides toll manufacturing services. The company was founded in 1992 and is headquartered in Avignon, France. As of September 3, 2018, Naturex S.A. operates as a subsidiary of Givaudan SA.

NRX Stock Price History

NRX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive NRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Naturex and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Olivier Rigaud (Age 53)
    CEO & Director
  • Mr. François De Gantes (Age 51)
    Chief Financial Officer
  • Mr. Frédéric Seguin (Age 44)
    Operations Director
  • Ms. Sarah Martin
    Chief Scientific Officer
  • Mr. Jean-Noël Lorenzoni (Age 41)
    Gen. Counsel and Company Sec.

NRX Stock Analysis - Frequently Asked Questions

How have NRX shares performed in 2024?

Naturex's stock was trading at €134.40 at the beginning of 2024. Since then, NRX shares have increased by 0.0% and is now trading at €134.40.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Naturex own?
This page (EPA:NRX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners